Literature DB >> 20114052

Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.

Eric Di Pasquale1, Jacques Fantini, Henri Chahinian, Marc Maresca, Nadira Taïeb, Nouara Yahi.   

Abstract

Alpha-synuclein (alpha-syn) is an amyloidogenic protein that plays a key role in the pathogenesis of Parkinson's disease (PD). The ability of alpha-syn oligomers to form ionic channels is postulated as a channelopathy mechanism in human brain. Here we identified a ganglioside-binding domain in alpha-syn (fragment 34-50), which includes the mutation site 46 linked to a familial form of PD (E46K). We show that this fragment is structurally related to the common glycosphingolipid-binding domain (GBD) shared by various microbial and amyloid proteins, including Alzheimer's beta-amyloid peptide. alpha-Syn GBD interacts with several glycosphingolipids but has a marked preference for GM3, a minor brain ganglioside whose expression increases with aging. The alpha-syn mutant E46K has a stronger affinity for GM3 than the wild-type protein, and the interaction is inhibited by 3'-sialyllactose (the glycone part of GM3). Alanine substitutions of Lys34 and Tyr39 in synthetic GBD peptides resulted in limited interaction with GM3, demonstrating the critical role of these residues in GM3 recognition. When incubated with reconstituted phosphatidylcholine bilayers, the E46K protein formed channels that are five times less conductive than those formed by wild-type alpha-syn, exhibit a higher selectivity for cations, and present an asymmetrical response to voltage and nonstop single-channel activity. This E46K-associated channelopathy was no longer observed when GM3 was present in phosphatidylcholine bilayers. This corrective effect was highly specific for GM3, since it was not obtained with the major brain ganglioside GM1 but was still detected in bilayer membranes containing both GM3 and GM1. Moreover, synthetic GBD peptides prevented the interaction of alpha-syn proteins with GM3, thus abolishing the regulatory effects of GM3 on alpha-syn-mediated channel formation. Overall, these data show that GM3 can specifically regulate alpha-syn-induced channel formation and raise the intriguing possibility that this minor brain ganglioside could play a key protective role in the pathogenesis of PD. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20114052     DOI: 10.1016/j.jmb.2010.01.046

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  27 in total

Review 1.  The role of lipids in α-synuclein misfolding and neurotoxicity.

Authors:  Cathryn L Ugalde; Victoria A Lawson; David I Finkelstein; Andrew F Hill
Journal:  J Biol Chem       Date:  2019-05-07       Impact factor: 5.157

Review 2.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

3.  Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein.

Authors:  Min-Kyu Cho; Hai-Young Kim; Claudio O Fernandez; Stefan Becker; Markus Zweckstetter
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

4.  Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

Authors:  Igor F Tsigelny; Yuriy Sharikov; Valentina L Kouznetsova; Jerry P Greenberg; Wolf Wrasidlo; Cassia Overk; Tania Gonzalez; Margarita Trejo; Brian Spencer; Kori Kosberg; Eliezer Masliah
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

Review 5.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

6.  α-Synuclein forms non-selective cation channels and stimulates ATP-sensitive potassium channels in hippocampal neurons.

Authors:  Sergej L Mironov
Journal:  J Physiol       Date:  2014-11-13       Impact factor: 5.182

Review 7.  Lipids: biomarkers of healthy aging.

Authors:  I Almeida; S Magalhães; A Nunes
Journal:  Biogerontology       Date:  2021-04-10       Impact factor: 4.277

8.  Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide.

Authors:  Coralie Di Scala; Nouara Yahi; Clément Lelièvre; Nicolas Garmy; Henri Chahinian; Jacques Fantini
Journal:  ACS Chem Neurosci       Date:  2012-12-27       Impact factor: 4.418

9.  Lipidomics Prediction of Parkinson's Disease Severity: A Machine-Learning Analysis.

Authors:  Hila Avisar; Cristina Guardia-Laguarta; Estela Area-Gomez; Matthew Surface; Amanda K Chan; Roy N Alcalay; Boaz Lerner
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 10.  Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.

Authors:  Nouara Yahi; Coralie Di Scala; Henri Chahinian; Jacques Fantini
Journal:  Glycoconj J       Date:  2021-07-30       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.